Introduction
Low platelet counts are a hallmark of pediatric immune thrombocytopenia (ITP), a blood condition that causes children to bleed and bruise more frequently. The body's immune system accidentally destroys its own platelets in an autoimmune disease. Given its unpredictable effects on health and quality of life, it is imperative to comprehend ITP in children. Some kids have minor symptoms and get better on their own, but others run a serious risk of bleeding out and need medical attention. The pathophysiology, etiology, clinical presentation, diagnosis, treatment, prognosis, complications, and patient/family education of pediatric ITP are all covered in detail in this article. It also covers recent findings and potential avenues for ITP treatment research. Providers, patients, and families can all better handle the difficulties associated with Pediatric ITP if they have a complete grasp of this disorder.
What Is the Pathophysiology of Pediatric Immune Thrombocytopenia?
An autoimmune disease known as pediatric immune thrombocytopenia (ITP) causes the immune system to attack and kill platelets necessary for blood coagulation. Platelet surface glycoproteins are bound by autoantibodies, mostly of the IgG class, designating them for splenic and other reticuloendothelial system tissue destruction.
Even though the bone marrow produces more megakaryocytes to compensate for the low platelet count, the destruction rate outpaces the creation rate, resulting in thrombocytopenia. Recent studies have demonstrated how cytotoxic T-cells target megakaryocytes and platelets directly and how T-helper cell dysregulation aggravates the autoimmune response.
Over more than a year, chronic ITP is associated with more intricate immune dysregulation and maybe hereditary components. Comprehending these mechanisms is essential to creating focused therapy and enhancing the results for kids with ITP.
What Is the Etiology of Pediatric Immune Thrombocytopenia?
Primary or idiopathic immune thrombocytopenia in pediatrics refers to ITP that frequently has no known cause. Nonetheless, several things can result in secondary ITP:
-
Infections: Infections include bacteria (like Helicobacter pylori) and viral infections (such as Epstein-Barr virus, cytomegalovirus, varicella zoster virus, and HIV).
-
Vaccinations: In rare cases, an immunological response to immunizations, such as the MMR vaccine, can cause ITP.
-
Autoimmune Disorders: Rheumatoid arthritis and systemic lupus erythematosus (SLE) are two disorders that can cause secondary ITP.
-
Genetic Predisposition: An increased risk may result from a family history of autoimmune illnesses.
-
Environmental Factors: Substance or chemical exposure is one type of potential trigger.
What Are Clinical Presentations?
A variety of symptoms are associated with pediatric immune thrombocytopenia (ITP), mainly stemming from a decreased platelet count that disrupts the blood's natural capacity to clot. Children who are impacted can have minor to severe symptoms in their clinical presentation. The following are the main features of the pediatric ITP clinical presentation:
-
Easy Bruising (Purpura): Purpura rash, or purple or red blotches on the skin brought on by tiny blood vessels leaking beneath the skin's surface, is a common symptom in children with ITP. Less or no trauma may result in bruises, which would suggest a lower platelet count.
-
Petechiae: These are microscopic, pinpoint red or purple patches that typically show up on the lower limbs. Petechiae are caused by small amounts of bleeding beneath the skin when there are insufficient platelets.
-
Nosebleeds (Epistaxis): Children with ITP often have nosebleeds, either severe or frequent. Because of their decreased capacity to clot, nosebleeds can be challenging to stop.
-
Bleeding Gums: Bleeding gums are common, especially when brushing or flossing. This is an additional indication of impaired platelet function.
-
Prolonged Bleeding from Cuts: Extended bleeding can occur from even small incisions. Halting bleeding is more difficult when the body is unable to produce a stable clot.
-
Menorrhagia: Menorrhagia, or heavy menstrual bleeding, in teenage girls may be a sign of ITP. If left untreated, this can cause severe blood loss and anemia.
Severe Symptoms
-
Internal Bleeding: Internal bleeding from ITP is possible in uncommon and severe cases. Abdominal pain, blood in the stools (melena), or blood in the urine (hematuria) are possible symptoms.
-
Intracranial Hemorrhage: Intracranial hemorrhage, or bleeding inside the brain, is the most dangerous consequence. Severe headaches, vomiting fits, disorientation, convulsions, and unconsciousness are among possible symptoms. An intracranial hemorrhage is a medical emergency that has to be treated right away.
Onset and Progression
-
Sudden Onset: ITP frequently appears out of the blue and occasionally follows a viral infection. Within days or weeks of the trigger event, symptoms may manifest.
-
Chronic ITP: While a lot of pediatric ITP instances go away in six months, some kids get chronic ITP, which lasts longer than a year. Long-term monitoring and care may be necessary for chronic ITP.
How Is Pediatric Immune Thrombocytopenia Diagnosed?
To confirm the diagnosis of pediatric immune thrombocytopenia (ITP) and rule out other possible causes of thrombocytopenia, a comprehensive clinical evaluation and laboratory tests are required.
Initial Assessment
-
Medical History: A thorough account of symptoms, recent infections, shots, drugs, and family medical history.
-
Physical Assessment: Look for bruises, purpura, and petechiae, which are indications of bleeding.
Laboratory Tests
-
Complete Blood Count (CBC): A low platelet count (<100,000/µL) with normal red and white blood cells is the result of a complete blood count (CBC).
-
Peripheral Blood Smear: A peripheral blood smear eliminates pseudo thrombocytopenia and confirms thrombocytopenia.
-
Examination of the Bone Marrow (if required): Examinations for further illnesses such as aplastic anemia or leukemia.
-
Additional Tests: Helicobacter pylori testing in chronic instances, HIV testing, and ANA testing for autoimmune illnesses.
Differential Diagnosis
-
Infections: Exclude any recent bacterial or viral illnesses.
-
Drug-induced Thrombocytopenia: Evaluate recent medication use.
-
Other Hematologic Disorders: Do not include Hemolytic Uremic Syndrome (HUS), aplastic anemia, or leukemia.
What Is the Management of Pediatric Immune Thrombocytopenia?
When platelet counts are higher than 30,000/µL and symptoms are moderate, attentive observation without prompt treatment may be necessary. In addition to being instructed to steer clear of potentially traumatizing activities, parents and other caregivers are taught the symptoms of bleeding.
Corticosteroids: When it comes to reducing the immune response and raising the platelet count, corticosteroids such as oral Prednisone or Dexamethason are frequently the first line of treatment. Since corticosteroids can cause adverse effects such as weight gain, hypertension, and weakening of the bones, they are often recommended for a brief period.
Intravenous Immunoglobulin (IVIG): Used in circumstances of substantial bleeding or when a prompt response is required, IVIG can swiftly raise platelet levels. It functions by preventing platelets from being destroyed and adjusting the immune system.
Anti-D Immunoglobulin: Given to children who test positive for Rh, Anti-D immunoglobulin can raise platelet counts by inducing a mild hemolytic reaction that displaces platelets from the immune system's focus. Children who are Rh-positive and have mild to moderate bleeding have this option.
Rituximab: When first-line treatments fail, patients with chronic or refractory ITP can benefit from the use of Rituximab, a monoclonal antibody that targets B-cells and lowers the generation of anti-platelet antibodies.
Thrombopoietin Receptor Agonists: Eltrombopag and romiplostim increase platelet production in the bone marrow and are especially helpful in treating chronic ITP that is unresponsive to other forms of treatment.
Surgical Management
Splenectomy: When medicinal therapy is ineffective for a chronic condition, surgical excision of the spleen may be considered. Splenectomy is a common but risky surgical procedure that should be carefully evaluated, as it increases the chance of infection throughout a lifetime.
Adjunctive Treatments
Platelet Transfusions: Because of its transient nature and the immune system's propensity to rapidly kill the transfused platelets, platelet transfusions are often only utilized in cases of life-threatening hemorrhage.
Immunosuppressive Agents: In situations of chronic immune thrombocytopenia that are refractory, further immunosuppressive medications such as Azathioprine and Mycophenolate mofetil may be taken into consideration.
Limitations on Activities and Safety Procedures: Youngsters with low platelet counts ought to stay away from high-risk activities like contact sports. Head injuries can be avoided by wearing helmets and other safety equipment when participating in activities. It is critical to treat infections right away to prevent making childhood ITP symptoms worse.
Instruction and Assistance
It is essential to inform families about the illness, available treatments, and warning signals of serious bleeding. To address the emotional and psychological effects of ITP on children and their families, it is crucial to offer psychosocial support.
Frequent Inspection
Routine follow-up visits with a pediatric hematologist are crucial to track platelet counts and evaluate the effectiveness of treatment. Treatment plans should be modified in light of the child's reaction and any negative effects.
Conclusion
A difficult autoimmune disease in children pediatric immune thrombocytopenia (ITP) is characterized by low platelet counts and bleeding risks. Clinical assessment and laboratory testing are used in the diagnosis process to rule out other possible causes of thrombocytopenia. Surgical procedures, sophisticated medicines, and observation are examples of management techniques. In addition to continuing research aimed at improving treatment outcomes and quality of life for children with ITP, education, and family support are essential.
